191 related articles for article (PubMed ID: 8888112)
1. Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides.
Forloni G; Tagliavini F; Bugiani O; Salmona M
Prog Neurobiol; 1996 Jul; 49(4):287-315. PubMed ID: 8888112
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity of beta-amyloid and prion peptides.
Forloni G
Curr Opin Neurol; 1996 Dec; 9(6):492-500. PubMed ID: 9007411
[TBL] [Abstract][Full Text] [Related]
3. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
[TBL] [Abstract][Full Text] [Related]
4. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
[TBL] [Abstract][Full Text] [Related]
5. On the biology of prions.
Prusiner SB; Gabizon R; McKinley MP
Acta Neuropathol; 1987; 72(4):299-314. PubMed ID: 3554880
[TBL] [Abstract][Full Text] [Related]
6. [Amyloidgenesis in prion disease].
Tsuboi Y
Brain Nerve; 2014 Jul; 66(7):849-55. PubMed ID: 24998829
[TBL] [Abstract][Full Text] [Related]
7. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
Selvaggini C; De Gioia L; Cantù L; Ghibaudi E; Diomede L; Passerini F; Forloni G; Bugiani O; Tagliavini F; Salmona M
Biochem Biophys Res Commun; 1993 Aug; 194(3):1380-6. PubMed ID: 8102526
[TBL] [Abstract][Full Text] [Related]
8. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
De Gioia L; Selvaggini C; Ghibaudi E; Diomede L; Bugiani O; Forloni G; Tagliavini F; Salmona M
J Biol Chem; 1994 Mar; 269(11):7859-62. PubMed ID: 7907586
[TBL] [Abstract][Full Text] [Related]
9. Overactivation of calcineurin induced by amyloid-beta and prion proteins.
Agostinho P; Lopes JP; Velez Z; Oliveira CR
Neurochem Int; 2008 May; 52(6):1226-33. PubMed ID: 18295934
[TBL] [Abstract][Full Text] [Related]
10. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.
Giese A; Kretzschmar HA
Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136
[TBL] [Abstract][Full Text] [Related]
11. The role of prion peptide structure and aggregation in toxicity and membrane binding.
Rymer DL; Good TA
J Neurochem; 2000 Dec; 75(6):2536-45. PubMed ID: 11080207
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanisms of degeneration of the central nervous system--prion structure and biology.
Prusiner SB; Stahl N; DeArmond SJ
Ciba Found Symp; 1988; 135():239-60. PubMed ID: 2900720
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
14. Amyloid associated proteins in Alzheimer's and prion disease.
Veerhuis R; Boshuizen RS; Familian A
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):235-48. PubMed ID: 15975027
[TBL] [Abstract][Full Text] [Related]
15. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides.
Soto C; Kascsak RJ; Saborío GP; Aucouturier P; Wisniewski T; Prelli F; Kascsak R; Mendez E; Harris DA; Ironside J; Tagliavini F; Carp RI; Frangione B
Lancet; 2000 Jan; 355(9199):192-7. PubMed ID: 10675119
[TBL] [Abstract][Full Text] [Related]
16. No influence of amyloid-beta-degrading neprilysin activity on prion pathogenesis.
Glatzel M; Mohajeri MH; Poirier R; Nitsch RM; Schwarz P; Lu B; Aguzzi A
J Gen Virol; 2005 Jun; 86(Pt 6):1861-1867. PubMed ID: 15914866
[TBL] [Abstract][Full Text] [Related]
17. Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins.
Taylor DR; Hooper NM
Semin Cell Dev Biol; 2007 Oct; 18(5):638-48. PubMed ID: 17822928
[TBL] [Abstract][Full Text] [Related]
18. The prionoses and other conformational disorders.
Wisniewski T; Aucouturier P; Soto C; Frangione B
Amyloid; 1998 Sep; 5(3):212-24. PubMed ID: 9818059
[TBL] [Abstract][Full Text] [Related]
19. Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.
Debatin L; Streffer J; Geissen M; Matschke J; Aguzzi A; Glatzel M
Neurodegener Dis; 2008; 5(6):347-54. PubMed ID: 18349519
[TBL] [Abstract][Full Text] [Related]
20. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.
Hornemann S; Glockshuber R
Proc Natl Acad Sci U S A; 1998 May; 95(11):6010-4. PubMed ID: 9600908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
